Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MicroTEC: Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated TFMP
NCT00908960Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- May 2009
- Primary completion
- Apr 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of enoxaparin in venous thromboembolism (VTE), sponsored by Beth Israel Deaconess Medical Center. Started May 2009; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00908960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00908960.